Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 2
2008 1
2009 4
2010 4
2011 2
2012 1
2013 1
2014 1
2016 5
2017 3
2018 2
2019 7
2020 8
2021 8
2022 7
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Retrospective Study of Cisplatin/Carboplatin, 5-Fluorouracil Plus Cetuximab (EXTREME) for Advanced-stage Salivary Gland Cancer.
Nakano T, Yasumatsu R, Hashimoto K, Kuga R, Hongo T, Yamamoto H, Matsuo M, Wakasaki T, Jiromaru R, Manako T, Toh S, Masuda M, Yamauchi M, Kuratomi Y, Uryu H, Nakashima T, Tamae A, Tanaka R, Taura M, Takeuchi T, Yoshida T, Nakagawa T. Nakano T, et al. Among authors: wakasaki t. In Vivo. 2022 Mar-Apr;36(2):979-984. doi: 10.21873/invivo.12790. In Vivo. 2022. PMID: 35241559 Free PMC article.
Small Cell Carcinoma in the Head and Neck.
Wakasaki T, Yasumatsu R, Masuda M, Matsuo M, Tamae A, Kubo K, Kogo R, Uchi R, Taura M, Nakagawa T. Wakasaki T, et al. Ann Otol Rhinol Laryngol. 2019 Nov;128(11):1006-1012. doi: 10.1177/0003489419853601. Epub 2019 Jun 4. Ann Otol Rhinol Laryngol. 2019. PMID: 31161776
Treatment Efficacy of PD-1 Inhibitor Therapy in Patients With Recurrent and/or Metastatic Salivary Gland Carcinoma.
Hashimoto K, Yasumatsu R, Kuga R, Hongo T, Yamamoto H, Matsuo M, Wakasaki T, Jiromaru R, Manako T, Toh S, Masuda M, Yamauchi M, Kuratomi Y, Uryu H, Nakashima T, Tamae A, Tanaka R, Taura M, Takeuchi T, Yoshida T, Nakagawa T. Hashimoto K, et al. Among authors: wakasaki t. Anticancer Res. 2022 Feb;42(2):981-989. doi: 10.21873/anticanres.15558. Anticancer Res. 2022. PMID: 35093898
49 results